Streamline Health Solutions

Streamline Health Solutions, Inc. engages in the provision of transformational data-driven solutions for healthcare organizations. Its solutions include Health Information Management (HIM), Coding and CDI, evaluator coding analysis platforms, financial management, and patient care. It also offers audit, custom integration, training, electronic image conversion, and database monitoring services. The company was founded by J. Brian Patsy in October 1989 and is headquartered in Alpharetta, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Streamline Health Solutions reports robust Q4 earnings and cost-saving integration

Streamline Health Solutions delivered robust financial results, showcasing strong revenue growth and a healthy balance sheet. The integration of recent acquisitions has led to substantial cost savings, while the company's focus on innovation and service delivery bodes well for future opportunities.

Streamline Health Solutions reports strong Q2 performance and innovation

Streamline Health Solutions delivered a strong performance in Q2 2023, demonstrating resilience in its financials and progress in scaling its technology offerings. The company's strengths lie in its ability to drive SaaS revenue growth, manage operating expenses, and innovate with AI-based tools. While facing challenges in the selling environment, Streamline Health has opportunities to leverage its cash position and technology advancements for future growth.

Streamline Health Solutions reports mixed Q3 results, focuses on SaaS growth and partnerships

Streamline Health Solutions reported mixed financial results for Q3 2023, with revenue growth in SaaS but a significant net loss due to a noncash impairment charge. The company is prioritizing improving its liquidity position and focusing on upsell and cross-sell opportunities. Progress is being made in relationships with key partners, and there is an opportunity for significant SaaS ARR growth in the future.

Streamline Health reports robust growth and innovation amidst financial challenges

Streamline Health Solutions demonstrated strong financial growth and operational efficiency in Q4 2022, driven by robust SaaS revenue and strategic initiatives.
While facing financial challenges and the goal of achieving breakeven EBITDA, the company's focus on innovation, client expansion, and revenue optimization positions it for future success.
With a solid foundation, a focus on impactful clients, and a commitment to product enhancement, Streamline Health has opportunities to capitalize on market demand and drive sustainable growth.

Streamline Health Solutions reports Q1 growth amidst breakeven targets

Streamline Health Solutions showed resilience with revenue growth and cost management efforts.
The company faces liquidity challenges but aims to achieve breakeven adjusted EBITDA by Q3 2023.
Opportunities lie in increasing SaaS revenue and leveraging integrated operations for growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Streamline Health Solutions, Inc. (STRM) CEO Tee Green on Q3 2020 Results - Earnings Call Transcript

Shares of Streamline Health Solns (NASDAQ:STRM) fell 2.33% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 500.00% over the past year to ($0.04), which beat the estimate of ($0.07).

Streamline Health Solns: Q3 Earnings Insights

Total First Nine Months of Fiscal 2020 Revenues of $8.4 million; $1.5 million Net Income; Adjusted EBITDA ($1.7 million)

Streamline Health® Reports Third Quarter 2020 Revenues of $2.6 million; ($1.1 million) Net Loss; Adjusted EBITDA ($0.7 million)

ATLANTA, GA, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc.  (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced that it will release its third quarter 2020 financial performance for the period that ended October 31, 2020, on Tuesday, December 8, 2020 after the close of the financial markets. 

Streamline Health® To Report Third Quarter 2020 Financial Performance on December 8, 2020

Additional Technologies to Better Manage Middle of Revenue Cycle

Streamline Health® Expands Reseller Agreement with Allscripts to include eValuator™ and CDI Solutions

Streamline Health Solutions, Inc. (STRM) CEO Tee Green on Q2 2020 Results - Earnings Call Transcript

Total First Half Fiscal 2020 Revenues of $5.7 million; $2.5 million Net Income; Adjusted EBITDA ($1.0 million)

Streamline Health® Reports Second Quarter 2020 Revenues of $2.9 million; ($1.1 million) Net Loss; Adjusted EBITDA ($0.4 million)

Automated Coding Analysis for Inpatient and Outpatient Care

Large Mid-Atlantic Health System Signs New Contract for Streamline Health® eValuator™

﻿ATLANTA, GA, Sept.  02, 2020  (GLOBE NEWSWIRE) --   Streamline Health Solutions, Inc.  (NASDAQ:STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced that it will release its second quarter 2020 financial performance for the period that ended July 31, 2020, on Wednesday, September 9, 2020 after the close of the financial markets. 

Streamline Health® To Report Second Quarter 2020 Financial Performance on September 9, 2020

Automated Coding Analysis for Inpatient and Outpatient Billing

LARGE MIDWEST ACADEMIC MEDICAL CENTER SIGNS NEW CONTRACT FOR STREAMLINE HEALTH® eVALUATOR™

Automated Coding Analysis for Inpatient Billing

MID ATLANTIC ACADEMIC HOSPITAL SIGNS NEW CONTRACT FOR STREAMLINE HEALTH® eVALUATOR™

Streamline Health Solutions, Inc.'s (STRM) CEO Tee Green on Q1 2020 Results - Earnings Call Transcript

First quarter 2020 revenue $2.8 million; loss from continuing operations ($1.0 million); adjusted EBITDA ($0.6 million)

Streamline Health® Reports First Quarter 2020 Financial Results

Streamline Health Solutions, Inc.'s (STRM) CEO Tee Green on Q4 2019 Results - Earnings Call Transcript

Atlanta, GA, April  22, 2020  (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled services and analytics to support revenue cycle optimization for healthcare enterprises, today announced financial results for the fourth quarter and fiscal year 2019 which ended January 31, 2020.

Streamline Health® Reports Fourth Quarter and Fiscal Year 2019 Financial Results

Streamline Health Solutions (STRM) CEO, Tee Green on Q3 2019 Results - Earnings Call Transcript

Streamline Health Solutions, Inc. (STRM) CEO Wyche Green, III on Q2 2019 Results - Earnings Call Transcript

Streamline Health Solutions, Inc. (STRM) CEO David Sides on Q1 2019 Results - Earnings Call Transcript

Streamline Health Solutions, Inc. (STRM) CEO David Sides on Q4 2018 Results - Earnings Call Transcript

News for Streamline Health Solutions Stock (STRM)